scholarly journals Brewing Green Beer

2021 ◽  
Vol 8 (4) ◽  
pp. 9-26
Author(s):  
Daniel Pashang Withers
Keyword(s):  
Drug Administration ◽  
New Technologies ◽  
Food And Drug Administration ◽  
Brewing Industry ◽  
Environmental Burden ◽  
Beer Brewing ◽  
Competitive Disadvantage ◽  
Tobacco Tax ◽  
Definition Of

New beer brewing technologies provide brewers with options to produce beer in more eco-friendly, less resource-intensive ways; however, as brewers adopt these technologies, they may find themselves straddling between the regulatory schemes of the Alcohol and Tobacco Tax and Trade Bureau (“TTB”) and the Food and Drug Administration (“FDA”). The two agencies have divided control over beers based on their ingredients, which places some beers under the TTB’s purview as “malted beverages” and others under the FDA’s purview. These distinctions have implications for the regulatory hurdles that brewers must overcome to market their products. Additional regulations that eco-friendly, green beers may face could provide higher hurdles than standard beers face, putting them at a competitive disadvantage. This Comment explores the relationships between beer brewing and the environment, new technologies that ease the environmental burden of beer brewing, and the regulatory boundaries affected by adopting these new technologies. By expanding its definition of “malted beverages,” the TTB can encourage the adoption of new eco-friendly technologies, avoid a regulatory quandary, and promote a healthy beer brewing industry.

The New Dietary Ingredient Safety Provision of DSHEA: A Return to Congressional Intent

2005 ◽  
Vol 31 (2-3) ◽  
pp. 285-304 ◽  
Author(s):  
Scott Bass ◽  
Emily Marden
Keyword(s):  
Dietary Supplements ◽  
Dietary Supplement ◽  
Drug Administration ◽  
Consumer Demand ◽  
Food And Drug Administration ◽  
Safety Standards ◽  
Education Act ◽  
Definition Of ◽  
Preventative Healthcare

In the ten years since the passage of the Dietary Supplement Health and Education Act of 1994 (“DSHEA”), dietary supplements have become a widely available and important element of individualized preventative healthcare. Congress created DSHEA in response to great consumer demand, thereby embracing the dietary supplement category and opening the door for the growth of the dietary supplement industry. DSHEA introduced an expansive definition of dietary supplements and laid out available claims and strict safety standards for such products.While the statute has remained unchanged since its passage in 1994, the Food and Drug Administration (“FDA”) appears to be in the process of re-interpreting sections of DSHEA in ways that could fundamentally limit the availability of dietary supplements. Specifically, FDA has been utilizing DSHEA's “new dietary ingredient” (“NDI”) safety provision to narrow the scope of ingredients that can be considered, even before addressing their safety, for use in dietary supplements.

Drugs or Dietary Supplements: FDA's Enforcement of DSHEA

1998 ◽  
Vol 17 (2) ◽  
pp. 296-302 ◽  
Author(s):  
Marlys J. Mason
Keyword(s):  
Dietary Supplements ◽  
Dietary Supplement ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Health Claims ◽  
Education Act ◽  
Definition Of

The Dietary Supplement Health and Education Act broadened the definition of a dietary supplement and loosened the restrictions for health claims on supplement labeling. The Act has left an unclear boundary between supplements and drugs. In this article, the author examines the legal debate surrounding the definition and regulation of drugs and supplements. The author also discusses recent Food and Drug Administration enforcement activities and court challenges.

The FDA Drug Approval Process: Focus on Pediatric Labeling

2001 ◽  
Vol 20 (3) ◽  
pp. 49-51
Author(s):  
Gretchen Brummel
Keyword(s):  
Drug Administration ◽  
Healthcare Professionals ◽  
Pediatric Patients ◽  
Food And Drug Administration ◽  
Drug Approval ◽  
Approval Process ◽  
Current Drug ◽  
History Of ◽  
Definition Of ◽  
Drug Approval Process

MANY HEALTHCARE professionals are not familiar with the current Food and Drug Administration (FDA) drug approval process, especially with regard to the system’s impact on pediatric patients. This column reviews the definition of pediatric labeling and its importance in the treatment of children, the history of drug regulation legislation, and the current drug approval process, proposes explanations for the deficit in pediatric labeling, and describes the steps that have been taken to correct this deficit.

FOOD REGULATORY ACTIVITIES1

1973 ◽  
Vol 36 (6) ◽  
pp. 349-353 ◽  
Author(s):  
Virgil O. Wodicka
Keyword(s):  
Quality Assurance ◽  
Drug Administration ◽  
Toxic Metals ◽  
Food And Drug Administration ◽  
Environmental Contaminants ◽  
Food Plant ◽  
Organic Chemicals ◽  
Food Ingredients ◽  
Definition Of ◽  
Plant Inspection

Current regulatory activities at the Food and Drug Administration cluster about several main lines of thrust. (a) More informative labeling. Examples are nutrient labeling, ingredient labeling on standardized foods, percentage declaration of characterizing ingredients, and on new foods, the definition of generic names. (b) Increasing emphasis on effective cooperation between State and Federal authorities. (c) Increased emphasis on food plant inspection. (d) More emphasis on inspection of quality assurance instead of only production. This includes quality assurance procedures applied to plant sanitation. (e) Increased attention to environmental contaminants, such as toxic metals and industrial organic chemicals. (f) Review of the safety of food ingredients with initial emphasis on the GRAS list.

Sign in / Sign up

Export Citation Format

Share Document